Explore active healthtech venture capital investors by stage, thesis, and check sizes. This directory highlights fund sizes, recent filings, and sector focus to help you prioritize investor outreach and improve match quality.
Complete database of 33 venture capital funds investing in healthtech startups. Find the right investor with $29B in combined assets under management.
The healthtech venture capital ecosystem has reached unprecedented scale, with 33 specialized funds managing $29B in assets.Investment activity has shown 23% growth year-over-year, reflecting strong investor confidence in the sector's long-term prospects.
In 2026, healthtech startups attracted $13Bacross 484 funding rounds, with the average fund size reaching$356M. This represents a maturing ecosystem where specialized funds are increasingly focusing on vertical-specific expertise.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary healthtech companies that are transforming industries through innovative technology and scalable business models.
There are 33 active VC funds specializing in healthtech investments, managing a combined $29B in assets under management. This represents one of the largest concentrations of specialized capital in the venture ecosystem, with funds ranging from $50M micro-funds to $2B+ growth-stage vehicles. The sector has attracted significant institutional capital due to its23% growth trajectory and strong exit potential.
Healthtech startups raise an average of $13M in Series A funding, with typical ownership ranging from 21-27%. This is above the cross-industry average due to the capital-intensive nature of many healthtech business models and longer development cycles. Series B rounds average $31M, reflecting the sector's ability to scale efficiently once product-market fit is achieved.
Top-performing healthtech VCs have generated 6x average returns average returnsover the past decade, with the best funds creating 18 unicorn companies. Leading funds like Healthtech Ventures A have demonstrated consistent performance through multiple market cycles, combining deep domain expertise with extensive portfolio support. Success rates for Series A investments reach 71% among top-quartile funds.
The typical healthtech funding process takes 4-6 months, from initial pitch to signed term sheet. This includes 2-4 weeks for initial screening, 4-8 weeks for due diligence, and 2-4 weeks for final negotiations and documentation. Healthtech startups often require longer diligence periods due to technical complexity and regulatory considerations, but experienced sector-focused VCs can move faster due to their domain expertise.
Top healthtech VCs prioritize technical differentiation, large addressable markets, and experienced teamswith deep domain knowledge. They look for startups that can demonstrate clear competitive moats, scalable business models, and strong early customer traction. Regulatory compliance, intellectual property position, and go-to-market strategy are particularly important in healthtech. The best VCs also value founders who can articulate long-term vision and have the technical depth to execute complex roadmaps.
Yes, healthtech VCs deployed $13B in 2026across 484 transactions, showing continued strong appetite for quality deals. While overall VC activity has normalized from peak 2021 levels, healthtech remains a priority sector for most institutional investors. Hot subsectors include AI-powered healthtech, Next-gen healthtech platforms, Enterprise healthtech solutions, which are seeing particularly strong investor interest and premium valuations.
Last updated: 1/11/2026 | Data aggregated from 33 VC funds, 484 deals, and 32 successful exits |About our methodology